Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 45K | Jun 21, 2023 | Direct | ||
Fulcrum Therapeutics, Inc. | Director | Stock Option (right to buy) | 30K | Jun 17, 2024 | Direct | ||
IDERA PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 26K | Jun 23, 2022 | Direct | ||
Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24K | Jun 5, 2024 | Direct | ||
Orchard Therapeutics plc | Director | Ordinary Shares | 0 | $0.46 | Jan 24, 2024 | Direct | |
Orchard Therapeutics plc | Director | Stock Option (Right to Buy) | 0 | Jan 24, 2024 | Direct |